International Stem Cell (OTCMKTS:ISCO) Stock Price Crosses Above 200 Day Moving Average – What’s Next?

Shares of International Stem Cell Corp. (OTCMKTS:ISCO) passed above its 200-day moving average during trading on Wednesday . The stock has a 200-day moving average of $0.16 and traded as high as $0.1781. International Stem Cell shares last traded at $0.1781, with a volume of 15,005 shares changing hands.

International Stem Cell Price Performance

The firm has a market capitalization of $1.42 million, a PE ratio of -2.97 and a beta of 0.07. The firm’s fifty day moving average is $0.17 and its two-hundred day moving average is $0.16.

International Stem Cell (OTCMKTS:ISCO) last issued its quarterly earnings data on Thursday, May 14th. The biotechnology company reported ($0.03) earnings per share (EPS) for the quarter. The business had revenue of $2.32 million for the quarter.

International Stem Cell Company Profile

International Stem Cell Corporation (OTCMKTS:ISCO) is a biotechnology company focused on the development and commercialization of human parthenogenetic stem cells (hpSC) for therapeutic and research applications. Parthenogenetic stem cells are derived from unfertilized human eggs and offer a scalable, ethically noncontroversial source of pluripotent cells. ISCO’s proprietary hpSC lines can be directed to differentiate into a wide variety of cell types, enabling preclinical programs in areas such as neurodegenerative disease, liver disease, diabetes and corneal regeneration.

In addition to its therapeutic pipeline, International Stem Cell maintains a research products division that supplies hpSC lines, differentiated cell populations and media formulations to academic institutions, biotechnology companies and contract research organizations.